Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-23

FDA Approved: ATORVASTATIN CALCIUM — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approval of Biocon Pharma Inc.'s atorvastatin calcium as an original generic application (ANDA) aligned to the reference product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

ORIG AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)